Tissue-type plasminogen activator prevents formation of intra-abdominal abscesses after surgical treatment of secondary peritonitis in a rat model

International Journal of Colorectal Disease

Volumn 22, Issue 7, 2007, Pages 819-825

  Buyne, Otmar R ^a   Bleichrodt, Robert P ^a   van Goor, Harry ^a   Verweij, Paul E ^a   Hendriks, Thijs ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Intra abdominal abscess; Peritonitis; Ratmodel; Recombinant tissue Plasminogen Activator (rtPA)

Indexed keywords

ALTEPLASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEREMIA; BACTEROIDES FRAGILIS; BODY WEIGHT; CELL COUNT; COLONY FORMING UNIT; CONTROLLED STUDY; DEBRIDEMENT; DRUG DOSE REGIMEN; ESCHERICHIA COLI; INOCULATION; MALE; MORTALITY; NONHUMAN; PERITONEUM CELL; PERITONITIS; PRIORITY JOURNAL; RAT; SURVIVAL; WISTAR RAT;

ABDOMINAL ABSCESS; ANIMALS; ASCITIC FLUID; CYTOKINES; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; INJECTIONS, INTRAPERITONEAL; LEUKOCYTE COUNT; MALE; PERITONITIS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 34249881063     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-006-0222-6     Document Type: Article

References (36)

1. Farthmann EH, Schoffel U (1998) Epidemiology and pathophysiology of intraabdominal infections (IAI). Infection 26(5):329-334 (September)
2. Bosscha K, van Vroonhoven TJ, van der Werken C (1999) Surgical management of severe secondary peritonitis. Br J Surg 86(11):1371-1377 (November)
3. Marshall JC, Innes M (2003) Intensive care unit management of intra-abdominal infection. Crit Care Med 31(8):2228-2237 (August)
4. Wong PF, Gilliam AD, Kumar S, Shenfine J, O'Dair GN, Leaper DJ (2005) Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. Cochrane Database Syst Rev 2:CD004539
5. Colizza S, Rossi S (2001) Antibiotic prophylaxis and treatment of surgical abdominal sepsis. J Chemother 13 Spec No 1(1):193-201 (November)
6. Schein M (2002) Surgical management of intra-abdominal infection: Is there any evidence? Langenbecks Arch Surg 387(1):1-7 (April)
7. Ince A, Eroglu A, Tarhan O, Bulbul M (2002) Peritoneal fibrinolytic activity in peritonitis. Am J Surg 183(1):67-69 (January)
8. Reijnen MM, Bleichrodt RP, van Goor H (2003) Pathophysiology of intra-abdominal adhesion and abscess formation, and the effect of hyaluronan. Br J Surg 90(5):533-541 (May)
9. Holmdahl L, Falkenberg M, Ivarsson ML, Risberg B (1997) Plasminogen activators and inhibitors in peritoneal tissue. APMIS 105(1):25-30 (January)
10. Collen D, Lijnen HR (2004) Tissue-type plasminogen activator: A historical perspective and personal account. J Thromb Haemost 2(4):541-546 (April)
11. Singh V (2004) Critical care assessment and management of acute ischemic stroke. J Vasc Interv Radiol 15(1 Pt 2):S21-S27 (January)
12. Katchan BM (2000) Thrombolytic therapy for pulmonary embolism. Can J Surg 43(6):411-416 (December)
13. Beathard GA (2001) Catheter thrombosis. Semin Dial 14(6):441-445 (November)
14. Ray TL, Berkenbosch JW, Russo P, Tobias JD (2004) Tissue plasminogen activator as an adjuvant therapy for pleural empyema in pediatric patients. J Intensive Care Med 19(1):44-50 (January)
15. Diamond IR, Wales PW, Connolly B, Gerstle T (2003) Tissue plasminogen activator for the treatment of intraabdominal abscesses in a neonate. J Pediatr Surg 38(8):1234-1236 (August)
16. Duch JM, Yee J (2001) Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis. Am J Kidney Dis 37(1):149-153 (January)
17. van Goor H, de Graaf JS, Kooi K, Sluiter WJ, Bom VJ, van der Meer J, Bleichrodt RP (1994) Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis. J Am Coll Surg 179(4):407-411 (October)
18. Rotstein OD, Kao J (1988) Prevention of intra-abdominal abscesses by fibrinolysis using recombinant tissue plasminogen activator. J Infect Dis 158(4):766-772 (October)
19. van Goor H, de Graaf JS, Kooi K, Bleichrodt RP (1995) Gentamycin reduces bacteremia and mortality rates associated with the treatment of experimental peritonitis with recombinant tissue plasminogen activator. J Am Coll Surg 181(1):38-42 (July)
20. Buyne OR, Bleichrodt RP, Verweij PE, Groenewoud HMM, van Goor H, Hendriks T (2006) A peritonitis model with low mortality and persisting intra-abdominal abscesses. Int J Exp Path 87(5):361-368 (October)
21. Parker SJ, Watkins PE (2001) Experimental models of gram-negative sepsis. Br J Surg 88(1):22-30 (January)
22. Rosman C, Bleichrodt RP, Wubbels GH, Sybesma T, Pasma P (1990) The effect of intra-operative lavage with Taurolidine or Saline solution on mortality and plasma endotoxin level in rats with generalized peritonitis. Surg Res Comm (7):269-275
23. Reijnen MMPJ, Skrabut EM, Postma VA, Burns JW, van Goor H (2001) Polyanionic Polysaccharides Reduce Intra-abdominal Adhesion and Abscess Formation in a Rat Peritonitis Model. J Surg Res 101(2):248-253 (December)
24. Bae JS, Ahn SJ, Yim H, Jang KH, Jin HK (2005) Prevention of intraperitoneal adhesions and abscesses by polysaccharides isolated from Phellinus spp in a rat peritonitis model. Ann Surg 241(3):534-540 (March)
25. Rotstein OD, Kao J (1988) Prevention of intra-abdominal abscesses by fibrinolysis using recombinant tissue plasminogen activator. J Infect Dis 158(4):766-772 (October)
26. Holmdahl L, Erikson E, al Jabreen M, Risberg B (1996) Fibrinolysis in human peritoneum during operation.Surgery 119(6):701-705 (June)
27. Holmdahl L (1997) The role of fibrinolysis in adhesion formation. Eur J Surg Suppl 577:24-31 (June)
28. Vipond MN, Whawell SA, Thompson JN, Dudley HA (1994) Effect of experimental peritonitis and ischaemia on peritoneal fibrinolytic activity. Eur J Surg 160(9):471-477 (September)
29. van Goor H (1996) Chapter 10: In vitro studies on the effect of recombinant tissue plasminogen activator on the rat fibrinolytic system. In: Fibrinolytic therapy in generalized peritonitis to prevent intraabdominal abscess formation. Thesis Radboud University Nijmegen
30. van Goor H, Bom VJ, van der Meer J, Sluiter WJ, Geerards S, van der Schaaf W, de Graaf JS, Bleichrodt RP (1996) Pharmacokinetics of human recombinant tissue-type plasminogen activator, administered intra-abdominally, in a rat peritonitis model. Eur Surg Res 28(4):287-294 (July)
31. Martineau L, Shek PN (2000) Peritoneal cytokine concentrations and survival outcome in an experimental bacterial infusion model of peritonitis. Crit Care Med 28(3):788-794 (March)
32. Montravers P, Maulin L, Mohler J, Carbon C (1999) Microbiological and inflammatory effects of murine recombinant interleukin-10 in two models of polymicrobial peritonitis in rats. Infect Immun 67(4):1579-1584 (April)
33. Sewnath ME, Olszyna DP, Birjmohun R, ten Kate FJ, Gouma DJ, van der Poll T (2001) IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J Immunol 166(10):6323-6331 (May 15)
34. Betjes MG, Tuk CW, Visser CE, Zemel D, Krediet RT, Arisz L, Beelen RH (1994) Analysis of the peritoneal cellular immune system during CAPD shortly before a clinical peritonitis. Nephrol Dial Transplant 9(6):684-692
35. Yao V, McCauley R, Cooper D, Platell C, Hall JC (2004) Peritoneal mesothelial cells produce cytokines in a murine model of peritonitis. Surg Infect (Larchmt) 5(3):229-236
36. Broche F, Tellado JM (2001) Defense mechanisms of the peritoneal cavity. Curr Opin Crit Care 7(2):105-116